Skip to main
  1. Stocks
  2. Dolby Laboratories
  3. Forecast
DLB

Dolby Laboratories (DLB) Stock Forecast & Price Target

Dolby Laboratories (DLB) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Dolby Laboratories is supported by a dominant IP licensing model, enviable margins, and strong cash flow generation, which together create limited downside and a high-quality earnings profile. Its revenue outlook is reinforced by broad adoption of Atmos, Vision, and image patent licensing, with that segment expected to grow 15% to 20% over the next few years and about 30% penetration of Atmos and Vision on 4K TVs, while newer initiatives like VDP, OptiView, and automotive expand monetization beyond device shipments. Near-term fundamentals also look constructive, with consensus calling for $372.8M in revenue and $1.19 in non-GAAP EPS, while management guidance of $362M to $392M and a dividend of $1.44 annually with $150 million left on buybacks underscore shareholder returns.

Bears say

Dolby Laboratories is challenged by a business model that still depends heavily on convincing device makers to adopt newer offerings such as Atmos and Vision, because revenue growth and higher royalties per device are tied to that transition rather than to the more mature foundational audio base. Its licensing-led revenue stream also depends on accurately forecasting customer device shipments, making supply-chain disruptions and semiconductor shortages a direct risk to visibility, attach rates, and near-term growth. Governance is another concern: as of the end of September 2022, the Dolby family and affiliates controlled 84% of combined voting power through Class B shares, limiting outside shareholders’ influence over capital allocation and strategic change.

Dolby Laboratories (DLB) has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.

Dolby Laboratories (DLB) Analyst Forecast & Price Prediction

Get the latest Dolby Laboratories (DLB) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Dolby Laboratories (DLB)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Dolby Laboratories (DLB) Forecast

Analysts have given Dolby Laboratories (DLB) a Buy based on their latest research and market trends.

According to 3 analysts, Dolby Laboratories (DLB) has a Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Dolby Laboratories (DLB)


Dolby Laboratories (DLB) Analyst Forecast & Price Prediction

Get the latest Dolby Laboratories (DLB) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Dolby Laboratories (DLB)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover DLB stock data and trends